Association of COVID-19 with New-Onset Alzheimer's Disease

J Alzheimers Dis. 2022;89(2):411-414. doi: 10.3233/JAD-220717.

Abstract

An infectious etiology of Alzheimer's disease has been postulated for decades. It remains unknown whether SARS-CoV-2 viral infection is associated with increased risk for Alzheimer's disease. In this retrospective cohort study of 6,245,282 older adults (age ≥65 years) who had medical encounters between 2/2020-5/2021, we show that people with COVID-19 were at significantly increased risk for new diagnosis of Alzheimer's disease within 360 days after the initial COVID-19 diagnosis (hazard ratio or HR:1.69, 95% CI: 1.53-1.72), especially in people age ≥85 years and in women. Our findings call for research to understand the underlying mechanisms and for continuous surveillance of long-term impacts of COVID-19 on Alzheimer's disease.

Keywords: Alzheimer’s disease; COVID-19; electronic health records; viral etiology.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease* / complications
  • Alzheimer Disease* / epidemiology
  • COVID-19 Testing
  • COVID-19* / complications
  • Female
  • Humans
  • Retrospective Studies
  • SARS-CoV-2